SCHEMBL30879095

SCHEMBL30879095

CC(C)[Si](C#Cc1c(-c2c(Cl)cccc2Cl)c(=O)n(C)c2nc(S(C)(=O)=O)ncc12)(C(C)C)C(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK2 O43353 8/20 0.37
NOD2 Q9HC29 7/20 0.37
ACVR1 Q04771 4/20 0.37
FGFR1 P11362 10/20 0.37
EGFR P00533 7/20 0.36
SRC P12931 5/20 0.36
FGFR2 P21802 3/20 0.36
FGFR4 P22455 3/20 0.36
FGFR3 P22607 3/20 0.36
WEE1 P30291 3/20 0.34
ABL1 P00519 2/20 0.33
PDGFRB P09619 2/20 0.33
PDGFRA P16234 2/20 0.33
MAPK14 Q16539 2/20 0.33
BMPR1B O00238 1/20 0.32
STK25 O00506 1/20 0.32
GAK O14976 1/20 0.32
EPHB6 O15197 1/20 0.32
JAK2 O60674 1/20 0.32
STK10 O94804 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30878746 0.91 WEE1 (0.43) RIPK2NOD2ACVR1FGFR1EGFR
SCHEMBL30878809 0.86 PTGS2 (0.34) ACVR1WEE1
SCHEMBL30878711 0.86 RIPK2 (0.34) RIPK2NOD2ACVR1FGFR1EGFR
SCHEMBL30878997 0.85 WEE1 (0.34) RIPK2NOD2ACVR1FGFR1EGFR
SCHEMBL30879159 0.84 RIPK2 (0.39) RIPK2NOD2ACVR1FGFR1EGFR
SCHEMBL30879128 0.83 FGFR1 (0.38) RIPK2ACVR1FGFR1EGFRSRC
SCHEMBL30879119 0.83 FGFR1 (0.38) RIPK2ACVR1FGFR1EGFRSRC
SCHEMBL30878706 0.83 CYP1A2 (0.37)
SCHEMBL30879168 0.82 MEN1 (0.36) RIPK2NOD2ACVR1FGFR1EGFR
SCHEMBL30879145 0.81 DPP4 (0.34) FGFR1EGFRWEE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed